Recruiting studies: Advanced Neoplasia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Ad
Phase 1 · 20 location(s) · TerSera Therapeutics LLC · NCT07310420 Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors
Phase 1 · 3 location(s) · NucMito Pharmaceuticals Co. Ltd. · NCT07292038 Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
Phase 2 · 1 location(s) · Tang-Du Hospital · NCT06055738 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · 312 location(s) · AstraZeneca · NCT06692738 A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
Phase 1 · 9 location(s) · Avacta Life Sciences Ltd · NCT04969835 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumo
Phase 2 · 181 location(s) · American Society of Clinical Oncology · NCT02693535 A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
Phase 3 · 28 location(s) · Daiichi Sankyo · NCT06174987 Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy
Phase 2 · 18 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT06924606 A Study of HDM2020 in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07098052 A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors
Phase 1 · 2 location(s) · Broadenbio Ltd., Co. · NCT06258408 To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
Phase 1 · 2 location(s) · Jiangsu Alphamab Biopharmaceuticals Co., Ltd · NCT06592417 A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
Phase 1/Phase 2 · 4 location(s) · Genfleet Therapeutics (Shanghai) Inc. · NCT07259590 A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Su
Phase 1 · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT07069335 A Study to Evaluate the Safety and Tolerability of SCTB14 as First-Line Therapy in Non-Small Cell Lung Cancer.
Phase 3 · 1 location(s) · Sinocelltech Ltd. · NCT07362459 A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Ac
Phase 1/Phase 2 · 74 location(s) · Nuvalent Inc. · NCT05384626 Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
Phase 1 · 1 location(s) · University of Chicago · NCT04361708 Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
Phase 2 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06002789 A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07016490 Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Phase 1 · 6 location(s) · Nuvectis Pharma, Inc. · NCT07315113 Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT04577014 Anti-GD2 ADC M3554 in Advanced Solid Tumors
Phase 1 · 11 location(s) · EMD Serono Research & Development Institute, Inc. · NCT06641908 A Study of AK129 in Patients With Advanced Malignant Tumors
Phase 1 · 1 location(s) · Akeso · NCT05645276 Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
Phase 1 · 1 location(s) · University Health Network, Toronto · NCT06977126 A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Phase 1/Phase 2 · 2 location(s) · RemeGen Co., Ltd. · NCT05205850 Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)
Phase 2 · 1 location(s) · Niek Wijnen · NCT07312292 Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Phase 2 · 1 location(s) · Gabriel Tinoco · NCT06528769 Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
Phase 2 · 1 location(s) · Fudan University · NCT04299581 Psychotherapy Intervention for Latinos With Adv Cancer
NA · 4 location(s) · Memorial Sloan Kettering Cancer Center · NCT04537936 Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced
Phase 2/Phase 3 · 18 location(s) · TuHURA Biosciences, Inc. · NCT06947928 RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
Phase N/A · 1 location(s) · Fudan University · NCT06524167

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →